65--TYPHOID VI POLYSACC

Opportunity Summary for Solicitation: 65--TYPHOID VI POLYSACC

Issuing Organization:
Department of Defense, Defense Logistics Agency, Troop Support Medical, DLA Troop Support
Contact Information:
For inquiries regarding this solicitation, contact the buyer listed in block 5 of the solicitation document. If access to additional information is required, use the DIBBS platform here and enter the solicitation number.

Important Dates:

• Posted Date: January 25, 2026
• Due Date: February 2, 2026

Project Scope and Objectives:
This solicitation pertains to the procurement of Typhoid VI Polysaccharide vaccine products. The objective is to support troop health and immunization efforts through the provision of this specific medical product.

Contract Type and Estimated Value:
The type of contract has not been specified in the available details. An estimated value for this procurement is not mentioned.

Mandatory Certifications/Registrations:

• Companies must be registered in the System for Award Management (SAM) and meet any required specifications outlined in the solicitation document.

Qualifications:

• Mandatory: Compliance with FDA regulations for medical products, including applicable certifications for the manufacture and supply of vaccines.
• Preferred: Previous experience in supplying similar medical products to government entities or military organizations.

Set-Aside Requirements:
Details regarding small business set-asides or other socioeconomic classifications are not provided.

Geographic Restrictions:
No specific geographic limitations are mentioned in the available information.

Key Technical Capabilities Needed:

• Ability to manufacture and supply Typhoid VI polysaccharide vaccines.
• Facilities that comply with current Good Manufacturing Practices (cGMP).

Specific Technologies or Methodologies Required:
The opportunity necessitates adherence to guidelines for the production of vaccines, which may include proprietary production methodologies that align with FDA and CDC standards.

Deliverables and Performance Standards:
The deliverables consist of Typhoid VI Polysaccharide vaccines, subject to the performance standards that are standard in the medical supplies sector, including efficacy, safety, and timely delivery.

Evaluation Criteria:
While specific evaluation criteria are not detailed, proposals will likely be evaluated based on compliance with mandatory specifications, price competitiveness, company experience, and capacity to meet project deadlines.

Preferred Qualifications:

• Demonstrated ability to meet delivery timelines and maintain product quality standards.
• Extensive experience in the pharmaceutical or biotechnology industry, specifically related to vaccine development and distribution.

Proposal Evaluation Process:
Proposals will be assessed based on the criteria set forth in the solicitation document, with emphasis on mandatory capabilities and qualifications. Companies interested should ensure alignment with the listed requirements to increase their chances of successful consideration.

This summary encapsulates the essential elements of the solicitation for potential bidders to evaluate their fit and readiness to respond effectively.